The biosensors market refers to the global market for devices that are used to detect and analyze biological and biochemical substances. Biosensors are analytical devices that are used in various applications such as medical diagnostics, food and environmental monitoring, and biodefense.
The biosensors market was valued at $17,500.0 million in 2018 and is expected to reach $38,600.2 million by 2026, registering a CAGR of 10.4% from 2019 to 2026.North America and Europe are the largest markets for biosensors, followed by the Asia-Pacific region. The key players in the biosensors market include Abbott Laboratories, AgaMatrix Holdings LLC, DowDupont Inc. (DuPont de Nemours, Inc.), F. Hoffmann-La Roche Ltd., General Electric (Biacore, Inc.), LifeScan, Inc., Medtronic Plc., Nova Biomedical, PHC Holdings Co., Ltd. (Ascensia Diabetes Care Holdings AG) and Siemens Healthcare.
The biosensors market is driven by the increasing demand for point-of-care testing and home-based diagnostic devices, the growing prevalence of chronic diseases such as diabetes, and the increasing adoption of biosensors in drug discovery and development. The market is also fueled by the increasing investments in research and development by governments and private organizations.
The market is segmented based on technology, application, and geography. The technology segment includes electrochemical biosensors, optical biosensors, piezoelectric biosensors, and thermal biosensors. The application segment includes medical diagnostics, food and environmental monitoring, biodefense, and drug discovery and development.
𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭- https://www.alliedmarketresearch.com/request-sample/1476
By product, the non-wearable biosensor segment accounted for the majority of the market share in 2018, and is expected to exhibit a major growth rate in the future, as the use of these sensors increases in non-clinical applications for real-time on-site. Monitoring of various manufacturing processes.
By technology, the electrochemical biosensor segment is expected to maintain its dominance in the coming years due to its precise sensitivity and rapid response. Moreover, electrochemical biosensors can be easily integrated into lab-on-chips (LOCs) to obtain better point-of-care (POC) analytical platforms.
Asia-Pacific is expected to grow at the highest rate during the forecast period. This is attributed to the increase in biotechnology R&D in the region. Key factors driving the growth of the biosensor market in Asia-Pacific include rising per capita income in several countries, increasing government initiatives to improve the healthcare sector, and the focus of leading manufacturers on expanding their geographic presence among emerging manufacturers. Asia-Pacific countries to tap into high growth opportunities in the market.
𝐏𝐫𝐨𝐜𝐮𝐫𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 (𝟐𝟎𝟎 𝐏𝐚𝐠𝐞𝐬 𝐏𝐃𝐅 𝐰𝐢𝐭𝐡 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬, 𝐂𝐡𝐚𝐫𝐭𝐬, 𝐓𝐚𝐛𝐥𝐞𝐬,𝐅𝐢𝐠𝐮𝐫𝐞𝐬)@ https://www.alliedmarketresearch.com/checkout-final/0f56f85f93da03bb5b95b4d5d7cab242
𝐌𝐚𝐣𝐨𝐫 𝐊𝐞𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 𝐢𝐧 𝐭𝐡𝐞 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 –
Abbott Laboratories
AgaMatrix Holdings LLC
Dow
Dupont Inc. (DuPont de Nemours, Inc.)
Hoffmann-La Roche Ltd.
General Electric (Biacore, Inc.)
LifeScan, Inc.
Medtronic Plc.
Nova Biomedical
PHC Holdings Co., Ltd. (Ascensia Diabetes Care Holdings AG)
Siemens Healthcare
𝐅𝐨𝐫 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐈𝐧𝐪𝐮𝐢𝐫𝐲: https://www.alliedmarketresearch.com/purchase-enquiry/1476
𝐊𝐞𝐲 𝐅𝐢𝐧𝐝𝐢𝐧𝐠𝐬 𝐎𝐟 𝐓𝐡𝐞 𝐒𝐭𝐮𝐝𝐲:
By technology, the electrochemical biosensors segment accounted for the highest market share of 28% in 2018 and is anticipated to grow at the fastest rate during the forecast period.
By product, the non-wearable segment dominated the market in 2018 and is anticipated to maintain its dominance during the forecast period.
By region, North America was the major shareholder and accounted for the highest share of 42% in 2018.
Asia-Pacific is expected to grow at a CAGR of 6.1% during the forecast period.
𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐢𝐧 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲:
Branded Generics Market Size : https://www.alliedmarketresearch.com/branded-generics-market-A10537
Biochips Market: https://www.alliedmarketresearch.com/biochip-market
𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
𝐂𝐨𝐧𝐭𝐚𝐜𝐭:
David Correa
5933 NE Win Sivers Drive#205,
Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
0 Comments